When a depression drug made things worse

Original Title

Paradoxical Depressive Response to Intranasal Esketamine in Treatment-Resistant Depression: A Case Series

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Two people with severe depression felt better at first after using a nasal spray called esketamine, but then got much sadder and thought about hurting themselves. When they stopped the spray, they felt better again.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Esketamine, approved for rapid suicide risk reduction, triggered suicidal ideation in two patients after initial improvement.

Esketamine is marketed as a suicide-prevention tool for treatment-resistant depression—this study shows it may, in rare cases, cause the very thing it’s meant to prevent.

Practical Takeaways

If you or someone you know is on esketamine and feels worse after a dose increase or after initial improvement, talk to your doctor immediately—discontinuation reversed symptoms in both cases.

low confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

20%
Lower QualityOverall Score

Publication

Journal

The American Journal of Case Reports

Year

2024

Authors

J. A. Ontiveros-Sanchez de la Barquera, Luis Alberto De La Garza García, S. García, Guillermo Sánchez Torres, Grecia Alejandra Perez Jalomo

Open Access
2 citations
Analysis v1